This retrospective study evaluates the effects of two different administration methods of the Pericapsular Nerve Group (PENG) Block on postoperative pain control, opioid consumption, and recovery in patients undergoing hip surgery. All patients in the study received: * PENG block via a catheter * Patient-Controlled Analgesia (PCA) with tramadol * Multimodal analgesia, including IV paracetamol and nonsteroidal anti inflammatory drugs (NSAIDs) as rescue analgesia The study compares two groups: 1. Intermittent Bolus Group: A researcher administered 20 mL of 0.25% bupivacaine every 4 hours. 2. Continuous Infusion Group: A pump delivered 5 mL/hour of 0.25% bupivacaine continuously. Both groups received the same total volume of local anesthetic over 24 hours. All PENG blocks were performed under ultrasound guidance at the end of surgery. This study aims to determine whether intermittent bolus or continuous infusion PENG block administration leads to better pain control, lower opioid consumption, and improved recovery outcomes.
Postoperative pain management after hip surgery remains a critical factor in recovery quality, opioid consumption, and overall patient outcomes. Among regional anesthesia techniques, the PENG Block is increasingly utilized for pain control due to its ability to provide effective analgesia while minimizing systemic opioid use. However, the optimal administration method of PENG block remains unclear. This retrospective cohort study evaluates the effectiveness of two different PENG block administration techniques in patients undergoing hip surgery: 1. Intermittent Bolus Group: A researcher manually administered 20 mL of 0.25% bupivacaine every 4 hours via a catheter placed under ultrasound guidance at the end of surgery. 2. Continuous Infusion Group: A pump delivered 5 mL/hour of 0.25% bupivacaine continuously via a catheter placed under ultrasound guidance at the end of surgery. Total local anesthetic volume over 24 hours was equal in both groups. Study Objectives: The primary objective is to compare intermittent bolus vs. continuous infusion PENG block administration in terms of: * Postoperative pain control (Visual Analog Scale) (VAS scores) * Total opioid consumption (morphine equivalent) * Time to first rescue analgesia * Quality of recovery (QoR-15 at 24 hours postoperative) Secondary outcomes include: * Postoperative nausea and vomiting (PONV) * Incidence of complications (hematoma, infection, nerve injury) This study aims to provide evidence on whether intermittent bolus or continuous infusion leads to better pain relief, reduced opioid consumption, and improved recovery in hip surgery patients.
Study Type
OBSERVATIONAL
Enrollment
82
Patients received intermittent bolus administration of the Pericapsular Nerve Group (PENG) Block via a catheter. A researcher manually administered 20 mL of 0.25% bupivacaine every 4 hours over a 24-hour period.
Patients received continuous infusion of the Pericapsular Nerve Group (PENG) Block via a catheter. A pump delivered 5 mL/hour of 0.25% bupivacaine continuously over a 24-hour period.
Tekirdağ Namık Kemal University Research Hospital
Tekirdağ, Turkey (Türkiye)
Total Postoperative Opioid Consumption
Total opioid consumption (including PCA tramadol) will be recorded and converted into morphine milligram equivalents (MME) for comparison between groups.
Time frame: From 0 hours (postoperatively) to 24 hours postoperatively, assessed at 0, 2, 6, 12, and 24 hours.
Quality of Recovery (QoR-15 Score)
The Quality of Recovery-15 (QoR-15) questionnaire will be used to assess the patient's postoperative recovery quality, including physical and emotional well-being. The QoR-15 is a validated tool that measures postoperative recovery across five domains: physical comfort, emotional state, psychological support, physical independence, and pain. Scale Range: 0 to 150 Interpretation: Higher scores indicate better recovery quality. Time Frame: Assessed at 24 hours postoperatively.
Time frame: Assessed at 24 hours postoperatively.
Time to First Rescue Analgesia
The time from surgery completion to the first NSAID rescue analgesia administration (ketorolac or dexketoprofen) will be recorded.
Time frame: From the end of surgery until the first administration of rescue analgesia, assessed up to 24 hours postoperatively.
Postoperative Pain Scores (VAS)
Postoperative pain levels will be assessed using the Visual Analog Scale (VAS, 0-10) where: * 0 = No pain * 10 = Worst possible pain * Higher scores indicate worse pain levels.
Time frame: From 0 hours (postoperatively) to 24 hours postoperatively, assessed at 0, 2, 6, 12, and 24 hours.
Postoperative Nausea and Vomiting (PONV) Incidence
Incidence of postoperative nausea and vomiting (PONV) will be recorded based on medical chart reviews and antiemetic administration (ondansetron IV use).
Time frame: From 0 hours (postoperatively) to 24 hours postoperatively.
Incidence of Complications
Any adverse events (hematoma, infection, nerve injury, hemodynamic instability, etc.) will be documented from patient records.
Time frame: From 0 hours (postoperatively) to 24 hours postoperatively.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.